[{"AccountsPayableCurrent_0_Q1_USD":6139000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":6301000.0,"AccruedMarketingCostsCurrent_0_Q1_USD":805000.0,"AccruedBonusesCurrent_0_Q1_USD":1198000.0,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":126500000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2260000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":4951000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":118823000.0,"EarningsPerShareDiluted_1_Q1_USD":0.01,"RepaymentsOfLongTermDebt_1_Q1_USD":11500000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":4454000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":198000.0,"LoansPayableCurrent_0_Q1_USD":46859000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":366811000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1594000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-15968000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":34100688.0,"OtherAssetsNoncurrent_0_Q1_USD":166000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":67181000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":67181000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":67181000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":67181000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":67180000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":48713000.0,"EarningsPerShareBasic_1_Q1_USD":0.01,"CostOfGoodsAndServicesSold_1_Q1_USD":37524000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1_Q1_USD":44777000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":386289000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":4951000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-51196000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":357000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1_Q1_shares":39411.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":76511000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":2645000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_1_Q1_USD":357000.0,"ProceedsFromIssuanceOfSecuredDebt_1_Q1_USD":192373000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1358000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":8873000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":9262000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":676000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_1_Q1_USD":392000.0,"LongTermLoansPayable_0_Q1_USD":145711000.0,"InvestmentIncomeNet_1_Q1_USD":212000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":50385000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":256000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q1_USD":10295000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q1_USD":27229000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":1336000.0,"WarrantsNotSettleableInCashFairValueDisclosure_0_Q1_USD":8043000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":521170000.0,"InventoryWorkInProcess_0_Q1_USD":1685000.0,"StockholdersEquity_0_Q1_USD":141063000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-359449000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":13145000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":6107000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":836000.0,"NetIncomeLoss_1_Q1_USD":450000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-6669000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-367647000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":323120000.0,"LiabilitiesCurrent_0_Q1_USD":244374000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":634793000.0,"Liabilities_0_Q1_USD":493730000.0,"InventoryNet_0_Q1_USD":15963000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2990000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":12474000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-108000.0,"GrossProfit_1_Q1_USD":38987000.0,"CommonStockValue_0_Q1_USD":34000.0,"CommonStockSharesOutstanding_0_Q1_shares":34306040.0,"CommonStockSharesIssued_0_Q1_shares":34306040.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":116178000.0,"AssetsCurrent_0_Q1_USD":223675000.0,"Assets_0_Q1_USD":634793000.0,"AdditionalPaidInCapital_0_Q1_USD":500478000.0,"AccountsReceivableNetCurrent_0_Q1_USD":85427000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":18814000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":823000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"InventoryRawMaterials_0_Q1_USD":5626000.0,"InventoryFinishedGoods_0_Q1_USD":8652000.0,"IncreaseDecreaseInInventories_1_Q1_USD":6714000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":10295000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":35069693.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":4454000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.015,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.655,"ShareBasedCompensation_1_Q1_USD":4951000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":31260000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2666000.0,"ProceedsFromConvertibleDebt_1_Q1_USD":138794000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":5061000.0,"OperatingExpenses_1_Q1_USD":33926000.0,"InterestPayableCurrent_0_Q1_USD":503000.0,"InterestPaidNet_1_Q1_USD":3456000.0,"InterestExpense_1_Q1_USD":4823000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q1_USD":386289000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":134881000.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":94383000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"WorkersCompensationLiabilityCurrent_0_Q1_USD":1522000.0,"Ticker":"COLL","CIK":"1267565","name":"COLLEGIUM PHARMACEUTICAL, INC","OfficialName":"Collegium Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"619097451.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]